Skip to Content

Biolase Inc BIOL

Morningstar Rating
$0.16 +0.02 (14.13%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BIOL is trading at a 46% discount.
Price
$0.16
Fair Value
$9.86
Uncertainty
Extreme
1-Star Price
$2.87
5-Star Price
$8.16
Economic Moat
Ccsk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BIOL is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.14
Day Range
$0.140.17
52-Week Range
$0.1350.00
Bid/Ask
$0.15 / $0.15
Market Cap
$3.02 Mil
Volume/Avg
16.7 Mil / 2.2 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.00
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intraoral scanners. It offers two categories of laser system products: Waterlase (all-tissue) systems and Diode (soft-tissue) systems which allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The majority of the company's revenue comes from the United States.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
192

Valuation

Metric
BIOL
Price/Earnings (Normalized)
Price/Book Value
1.07
Price/Sales
0.00
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
BIOL
Quick Ratio
0.62
Current Ratio
1.40
Interest Coverage
−6.77
Quick Ratio
BIOL

Profitability

Metric
BIOL
Return on Assets (Normalized)
−59.43%
Return on Equity (Normalized)
−353.48%
Return on Invested Capital (Normalized)
−90.02%
Return on Assets
BIOL
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ABT
Abbott LaboratoriesMkbqq$205.8 Bil
SYK
Stryker CorpPvcmf$134.3 Bil
MDT
Medtronic PLCBdydx$111.0 Bil
BSX
Boston Scientific CorpQppfh$98.5 Bil
EW
Edwards Lifesciences CorpCcfby$51.2 Bil
DXCM
DexCom IncCcfr$46.9 Bil
ZBH
Zimmer Biomet Holdings IncRhtz$25.4 Bil
ALGN
Align Technology IncMfchw$23.0 Bil
PHG
Koninklijke Philips NV ADRXcwhjrr$18.4 Bil
PODD
Insulet CorpCldzk$11.8 Bil

Sponsor Center